Doctor's Bio
Board Certifications
American Board of Internal Medicine
Affiliations
Emory
Education & Training
- Medical School: University of Ibadan
- Internship: Morehouse School of Medicine
- Residency: Morehouse School of Medicine
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations.
Wheless MC, Zemla TJ, Hubbard JM, Strickler JH, Gbolahan OB, Wilson L, Waechter B, Ou FS, Nixon AB, Bekaii-Saab TS, Ciombor KK
The oncologist. 2025;
PMID: 40515475 - First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.
Carneiro BA, Gbolahan OB, Abdul Razak AA, Hilton JF, Lambert AW, Hood J, Pluta M, Bragulat V, Sanai E, Kumar R, Jodrell DI, LoRusso PM
Cancer research communications. 2025;5(6):896-905.
PMID: 40354065 - Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101.
Grewal US, Gbolahan OB, Takalkar AM, Halperin DM
Future oncology (London, England). 2025;21(11):1357-1363.
PMID: 40162745 - XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial.
Phillips MJ, Alese OB, Horvat NK, Greene E, Gbolahan OB, Coleman K, Doxie DB, Parihar V, Mahdi ZK, McCook-Veal A, Switchenko JM, Diab M, Herting CJ, Paulos CM, El-Rayes BF, Lesinski GB
Oncoimmunology. 2025;14(1):2475620.
PMID: 40079916 - Feasibility and Safety of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Neuroendocrine Tumor in a Patient With Sickle Cell Anemia.
Lawal IO, Gbolahan OB, Marcus C, Jones AT, Shaib WL, Muzahir S
Clinical nuclear medicine. 2025;
PMID: 40029803 - A pilot study of the immune microenvironment of GI neuroendocrine carcinoma.
McDonald A, Avadhani V, Oprea-Ilies G, Zakka K, Lesinski GB, Gbolahan OB, Alese O
Endocrine-related cancer. 2024;
PMID: 39045861 - Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
Gbolahan OB, Zhi X, Liu Y, Shah MM, Kooby DA, Alese OB
JAMA network open. 2024;7(1):e2351502.
PMID: 38206623 - Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.
Villalobos A, Dabbous HH, Little O, Gbolahan OB, Akce M, Lilly MA, Bercu Z, Kokabi N
Current oncology (Toronto, Ont.). 2023;30(12):10100-10110.
PMID: 38132368 - Outcomes of responders to PD-1/PD-L1 inhibitors who discontinue therapy after sustained disease control.
Sharma H, Moturi KR, Pankratz VS, Yilmaz E, Gbolahan OB, Kumar A, Hashemi-Sadraei N
Journal of cancer research and clinical oncology. 2023;149(11):8673-8680.
PMID: 37115270 - A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors.
Gbolahan OB, O'Neil BH, McRee AJ, Sanoff HK, Fallon JK, Smith PC, Ivanova A, Moore DT, Dumond J, Asher GN
Clinical and translational science. 2022;15(5):1304-1315.
PMID: 35157783
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.